820 results on '"Bhalla K"'
Search Results
2. A Preshower Photon Multiplicity Detector for the WA98 Experiment
3. Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
4. BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
5. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
6. HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist
7. Athena: Speciality Certificate Examination case for Paediatrics and Genetics
8. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells
9. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
10. Experimental Investigation of the Response of the Human Lower Limb to the Pedestrian Impact Loading Environment
11. Designing Road Vehicles For Pedestrian Protection
12. Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
13. Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance
14. Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
15. COMMUNITY-BASED STUDY ON SEROPREVALENCE OF HERPES SIMPLEX VIRUS TYPE 2 INFECTION IN NEW DELHI
16. Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
17. Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)
18. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection
19. EPIDEMILOGICAL ANALYSIS OF NEISSERIA GONORRHOEAE ISOLATES BY ANTIMICROBIAL SUSCEPTIBILITY TESTING, AUXOTYPING AND SEROTYPING
20. Global road safety: a well-travelled road?
21. Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
22. A complex rearrangement involving simultaneous translocation and inversion is associated with a change in chromatin compaction
23. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells
24. Building national estimates of the burden of road traffic injuries in developing countries from all available data sources: Iran
25. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells
26. Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA
27. Intracranial bleed mimicking acute myocardial infarction
28. 28Si(32S) fragmentation at 3.7 A, 14.6 A and 200 A GeV
29. On the production of slow particles in high energy heavy ion collisions
30. Collective bounce-off phenomenon in139La+Ag(Br) reaction at 1.1 A GeV energy
31. Experimental results of heavy ion interactions in emulsions
32. AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has significant activity in imatinib-resistant Bcr-Abl positive chronic myeloid leukemia (CML): 8
33. Local particle densities and global multiplicities in central heavy ion interactions at 3.7, 14.6, 60 and 200A GeV
34. A systematic study of the energy independent behaviour of the fragmentation regions in16O-Em interactions from 3.7 to 200A GeV
35. Energy, target, projectile and multiplicity dependences of intermittency behaviour in high energy O(Si, S) induced interactions
36. Lipid and fatty acid analysis of uninfected and granulosis virus-infected Plodia interpunctella larvae
37. Lipid and fatty acid analysis of the Plodia interpunctella granulosis virus (PiGV) envelope
38. Perception regarding skewed sex ratio among reproductive age group females in an urban slum of Haryana
39. Comparison Of Beclomethasone Dipropionate Aerosol And Prednisolone In Reversible Airways Obstruction
40. BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
41. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
42. (He,H2+) dynamics revisited.
43. Molecular analysis of Severe Mental Retardation associated 16p-chromosomal breakpoint
44. Systematics of inclusive photon production in 158·A GeV Pb induced reactions on Ni, Nb, and Pb targets
45. BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
46. Characteristics of56Fe-emulsion interactions at 1.7 GeV/A
47. On the solution of the stability problem of elastic rods subjected to triangularly distributed, tangential follower forces
48. A study of angular correlations of projectile and target fragments in 1.4 A GeV Kr+Ag(Br) collisions
49. Transverse momenta of secondaries from 200 GeV/c proton-nucleus interactions
50. Search for anomalous interaction mean free paths of charge, 2≦Z≦18 projectile fragments in emulsions exposed to 1.8 A GeV40Ar ions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.